Driver mutations are identifiable in >90% of all thyroid cancers, with the most common driver mutations in advanced thyroid cancer patients being mitogen-activated protein kinase, herein referred to as MAPK, pathway mutations in either BRAF or RAS [2]. The gene discussed is WNK2; the disease is thyroid gland carcinoma.